SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-031255
Filing Date
2004-02-27
Accepted
2004-02-27 15:50:18
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 976290
3 DEVELOPMENT AND INITIAL SUPPLY AGREEMENT dex1020.htm EX-10.20 181900
4 LIST OF SUBSIDIARIES dex211.htm EX-21.1 5897
5 CONSENT OF KPMG LLP dex231.htm EX-23.1 2124
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex232.htm EX-23.2 1688
7 CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 dex311.htm EX-31.1 5018
8 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex321.htm EX-32.1 6296
9 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex322.htm EX-32.2 6274
10 BIOMARIN/GENZYME LLC FINANCIAL STATEMENTS dex991.htm EX-99.1 153982
  Complete submission text file 0001193125-04-031255.txt   1342065
Mailing Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949
Business Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949 4158846700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26727 | Film No.: 04635130
SIC: 2834 Pharmaceutical Preparations